Hepatic profile analyses of tipranavir in Phase II and III clinical trials
-
* Corresponding author: Jaromir Mikl jmikl1@nycap.rr.com
BMC Infectious Diseases 2009, 9:203 doi:10.1186/1471-2334-9-203
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 15 Apr 2009 | |
| Reviewer's Report | Marina Nunez | 26 May 2009 | |
| Reviewer's Report | Nicola Abrescia | 29 May 2009 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 03 Sep 2009 |
| Reviewer's Report | Nicola Abrescia | 18 Sep 2009 | |
| Reviewer's Report | Marina Nunez | 05 Oct 2009 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 17 Nov 2009 |
| Resubmission - Version 4 | Manuscript | Author's comment | 25 Nov 2009 |
| Editorial acceptance | 27 Nov 2009 | ||
| Published | 14 Dec 2009 |